its available if you seek it, but only through the right channels (prescription or careful research supply)
Researchers analyzed the records of about 45 million people with at least one inpatient or outpatient visit between 2011 and 2023 to determine trends in new GLP-1 receptor agonist prescribing
doi: 10.1016/j.amsu.2020.10.003 59 AsazumaTToyamaYMaruiwaHFujimuraYHirabayashiK
It decreased tyrosinase activity in B16 cells, inhibited melanin synthesis, and interacted with the catalytic site, preventing its binding with L-Dopa, and thereby reducing the enzymes catalytic activity (Li J
(PubMed) Rao CV, Rivenson A, Simi B, Reddy BS
Over time, this buildup can contribute to neurological disorders, chronic fatigue, weakened immune function, and organ damage